Pharmalucence, Inc. is recalling 621 units of the Kit for the Preparation of Technetium TC-99M Mebrofenin, a radiopharmaceutical drug used in diagnostic imaging. The recall was initiated because the product failed stability specifications, meaning the drug may not maintain its intended potency or quality through its labeled shelf life. Consumers should be aware that this affects both 5-count and 30-count packages distributed nationwide. If you have been treated with this medication, you should consult your healthcare provider to determine if any follow-up is necessary.
The drug failed stability testing, which can result in the medication not working as intended during diagnostic procedures, potentially leading to inaccurate medical imaging results or the need for repeat scans.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.